diaziquone ( azq ) and etoposide ( vp-16 ) were administered as simultaneous 5-day continuous infusions to 27 patients with acute leukemia ( 22 with acute myeloid leukemia ( aml ) , three with chronic myeloid leukemia in blast crisis ( cml-b ) , and two with acute lymphocytic leukemia ) at four different doses in a phase i trial .
C0015133
etoposide
C0023467
acute myeloid